The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Transcatheter treatment for refractory angina with the coronary sinus Reducer

EuroIntervention 2014;9:1158-1164. DOI: 10.4244/EIJV9I10A196

1. Department of Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel, and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 2. Antwerp Cardiovascular Center, ZNA Middelheim, Antwerp, Belgium; 3. Neovasc, Inc., Richmond, BC, Canada

Aims: To evaluate the clinical efficacy of the coronary sinus (CS) Reducer in attenuating angina severity in patients suffering from severe refractory angina.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions

Latest news